Preview

Experimental and Clinical Gastroenterology

Advanced search

Wilson-Konovalov disease in a patient after COVID-19 infection

https://doi.org/10.31146/1682-8658-ecg-199-3-161-165

Abstract

We present a rare clinical case of Wilson-C onovalov disease in a patient after a new coronavirus infection. The development of her neurological symptoms, which allowed to specify the etiology of the already existing liver damage, may have been provoked by the COVID-19 infection, in which the central nervous system is frequently involved in the pathological process. Wilson-C onovalov disease was suspected due to the presence of neurological manifestations and signs of liver cirrhosis. Subsequently, the diagnosis was confi rmed genetically, copper metabolism disorders were identifi ed and pathogenetic therapy was prescribed to eliminate excess copper from the body.

About the Authors

A. V. Aparkina
Saratov State Medical University named after V.I. Razumovsky
Russian Federation

Alena V. Aparkina -Department of Hospital Therapy of medical faculty, Associate professor, Ph.D in Medicine.

Saratov



E. I. Kashkina
Saratov State Medical University named after V.I. Razumovsky
Russian Federation

Elena I. Kashkina -Department of Hospital Therapy of medical faculty, Professor, MD.

Saratov



A. A. Markova
Saratov State Medical University named after V.I. Razumovsky
Russian Federation

Anna A. Markova -Department of Hospital Therapy of medical faculty, Assistant, Ph.D in Medicine.

Saratov



K. D. Dorogoikina
Saratov State Medical University named after V.I. Razumovsky
Russian Federation

Ksenia D. Dorogoikina -Department of Hospital Therapy of medical faculty, Assistant.

Saratov



R. V. Lyakisheva
State healthcare institution Regional Clinical Hospital
Russian Federation

Rimma V. Lyakisheva -head of Department of gastroenterology; Ph.D in Medicine.

Saratov



References

1. Lopatkina T. N. Wilson’s disease. In: Gastroenterology Manual. Moscow. 2010, pp. 579–581. (In Russ.)

2. Gomes A., Dedoussis G. V. Geographic distribution of ATP7B mutations in Wilson disease. Ann. Hum. Biol. 2016;43:1–8. doi: 10.3109/03014460.2015.1051492

3. Maevskaya M. V., Vedernikova A. V., Ivashkin V. T., et al. Wilson’s disease (clinical case presentation). Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2002; (5): 20–22. (In Russ.)

4. European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson’s Disease. J. Hepatol. 2012; 56: 671–685. doi: 10.1016/j.jhep.2011.11.007

5. Ferenci P., Roberts E. A. Defi ning Wilson disease phenotypes: from the patient to the bench and back again. Gastroenterology. 2012;142(4):692–696. doi: 10.1053/j.gastro.2012.02.035

6. Federal clinical guidelines for the diagnosis and treatment of Wilson–Konovalov disease (hepatolenticular degeneration). Moscow. 2015. 61 P. (In Russ.)

7. Mason A., Sallie R., Perillo P., et al. Prevalence of herpes-viridae and hepatitis E virus DNA in the liver of patients with non-A , non-B fulminant hepatic failure. Hepatology. 1996; 24 (6): 1361–1365. doi: 10.1002/hep.510240608.

8. Harma M., Hockerstedt K., Lautenschlager I. Human herpes-v irus VI and acute liver failure. Transplantation. 2003; 76 (3): 536–539.

9. Lee I. C., Huo T. I., Huang Y. H. Gastrointestinal and liver manifestations in patients with COVID-19. J. Chin. Med. Assoc. 2020;83:521–523. doi: 10.1097/JCMA.0000000000000319

10. Mao L., Jin H., Wang M., et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):1–9. doi: 10.1001/jamaneurol.2020.1127

11. Tsimmerman Ya. S. Wilson’s disease – hepatocerebral dystrophy. Klin. med. 2017; 95(4): 310–315. (In Russ.) doi:10.18821/0023–2149–2017-95–4–310–315

12. Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet. 2020; 395(10223):497-506. doi:10.1016/S0140–6736(20)30183–5


Review

For citations:


Aparkina A.V., Kashkina E.I., Markova A.A., Dorogoikina K.D., Lyakisheva R.V. Wilson-Konovalov disease in a patient after COVID-19 infection. Experimental and Clinical Gastroenterology. 2022;(3):161-165. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-199-3-161-165

Views: 198


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)